Patil, K.; Gujarathi, N.; Sharma, C.; Ojha, S.; Goyal, S.; Agrawal, Y.
Quality-by-Design-Driven Nanostructured Lipid Scaffold of Apixaban: Optimization, Characterization, and Pharmacokinetic Evaluation. Pharmaceutics 2024, 16, 910.
https://doi.org/10.3390/pharmaceutics16070910
AMA Style
Patil K, Gujarathi N, Sharma C, Ojha S, Goyal S, Agrawal Y.
Quality-by-Design-Driven Nanostructured Lipid Scaffold of Apixaban: Optimization, Characterization, and Pharmacokinetic Evaluation. Pharmaceutics. 2024; 16(7):910.
https://doi.org/10.3390/pharmaceutics16070910
Chicago/Turabian Style
Patil, Kiran, Nayan Gujarathi, Charu Sharma, Shreesh Ojha, Sameer Goyal, and Yogeeta Agrawal.
2024. "Quality-by-Design-Driven Nanostructured Lipid Scaffold of Apixaban: Optimization, Characterization, and Pharmacokinetic Evaluation" Pharmaceutics 16, no. 7: 910.
https://doi.org/10.3390/pharmaceutics16070910
APA Style
Patil, K., Gujarathi, N., Sharma, C., Ojha, S., Goyal, S., & Agrawal, Y.
(2024). Quality-by-Design-Driven Nanostructured Lipid Scaffold of Apixaban: Optimization, Characterization, and Pharmacokinetic Evaluation. Pharmaceutics, 16(7), 910.
https://doi.org/10.3390/pharmaceutics16070910
